FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 42291-458 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA078152
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20251117
Package count1

External sources

Source: openFDA. Public-domain (CC0).